Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-25-003549
Filing Date
2025-01-24
Accepted
2025-01-24 14:33:53
Documents
1
Period of Report
2025-01-22

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 5845
  Complete submission text file 0001493152-25-003549.txt   7409
Mailing Address 1001 NORTH US HWY 1 SUITE 504 JUPITER FL 33477
Business Address 1001 NORTH US HWY 1 SUITE 504 JUPITER FL 33477 (561) 406-6154
JUPITER NEUROSCIENCES, INC. (Issuer) CIK: 0001679628 (see all company filings)

EIN.: 474828381 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ZIOPHARM ONCOLOGY, INC. ONE FIRST AVENUE, PARRIS BLDG 34 BOSTON MA 02129
Business Address
Weis Holger (Reporting) CIK: 0001846984 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41265 | Film No.: 25553627